NOZOMI Trademark

Trademark Overview


On Tuesday, February 11, 2025, a trademark application was filed for NOZOMI with the United States Patent and Trademark Office. The USPTO has given the NOZOMI trademark a serial number of 99036634. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 22, 2025. This trademark is owned by Nozomi Salud Panamá S.A.. The NOZOMI trademark is filed in the Advertising, Business and Retail Services and Pharmaceutical Products categories with the following description:

Blood plasma; Blood for medical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Analgesic preparations

Wholesale store services for pharmaceutical preparations and medical supplies; Retail store services for pharmaceutical preparations and medical supplies; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry
nozomi

General Information


Serial Number99036634
Word MarkNOZOMI
Filing DateTuesday, February 11, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of two tear drop designs in mirror image forming a circular design next to the letters NOZOMI in stylized form.
Goods and ServicesBlood plasma; Blood for medical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Analgesic preparations
Indication of Colors claimedThe color(s) blue and dark blue is/are claimed as a feature of the mark.
Goods and ServicesWholesale store services for pharmaceutical preparations and medical supplies; Retail store services for pharmaceutical preparations and medical supplies; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNozomi Salud Panamá S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCiudad de Panamá 0001
PA

Trademark Events


Event DateEvent Description
Tuesday, February 11, 2025NEW APPLICATION ENTERED
Tuesday, February 11, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 11, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 21, 2025NON-FINAL ACTION WRITTEN
Monday, July 21, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NON-FINAL ACTION WRITTEN
Friday, July 18, 2025ASSIGNED TO EXAMINER